Aevum is pioneering the discovery and development of therapeutic molecules derived from exercised muscle to treat diseases that are known to benefit from exercise. Our lead program is being developed for the treatment of Parkinson’s disease and other related neurodegenerative disorders. Focus/Therapeutic Area: Neurology Stage/Status: Seed Website: —
Aevum Therapeutics Read More »
Advancing off-the-shelf dopamine neuron replacement therapies as a disease-modifying and potentially curative treatment for neurological disorders. Our proprietary platform leverages a novel approach to treating central nervous system disorders, such as Parkinson’s disease, by replacing neurons lost due to neurodegeneration. Focus/Therapeutic Area: Neurology Stage/Status: Series A Website: https://www.kenaitx.com
Kenai Therapeutics Read More »
Tortugas is developing therapeutics for neurological diseases of high unmet need. We focus on translational approaches to allow for rapid identification of efficacy and impact. Focus/Therapeutic Area: Neurology Stage/Status: Seed Website: —
Tortugas Neuroscience Read More »
